OPTIMI HEALTH CORP. (8BN) - Total Liabilities

Latest as of December 2025: €9.22 Million EUR ≈ $10.78 Million USD

Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) has total liabilities worth €9.22 Million EUR (≈ $10.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does OPTIMI HEALTH CORP. generate cash to assess how effectively this company generates cash.

OPTIMI HEALTH CORP. - Total Liabilities Trend (2022–2025)

This chart illustrates how OPTIMI HEALTH CORP.'s total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of OPTIMI HEALTH CORP. to evaluate the company's liquid asset resilience ratio.

OPTIMI HEALTH CORP. Competitors by Total Liabilities

The table below lists competitors of OPTIMI HEALTH CORP. ranked by their total liabilities.

Company Country Total Liabilities
Lion Forest Industries Bhd
KLSE:8486
Malaysia RM160.29 Million
LL Lucky Games publ AB
ST:LADYLU
Sweden Skr42.04 Million
Salee Industry Public Company Limited
BK:SALEE
Thailand ฿269.25 Million
Canuc Resources Corp
V:CDA
Canada CA$239.20K
Norwegian Block Exchange AS
OL:NBX
Norway Nkr74.34 Million
Safestore Holdings Plc
LSE:SAFE
UK GBX1.30 Billion
Komputronik S.A.
WAR:KOM
Poland zł251.25 Million
DigiCAP Co. Ltd
KQ:197140
Korea ₩19.37 Billion

Liability Composition Analysis (2022–2025)

This chart breaks down OPTIMI HEALTH CORP.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OPTIMI HEALTH CORP. market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.12 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.84 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.65 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OPTIMI HEALTH CORP.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OPTIMI HEALTH CORP. (2022–2025)

The table below shows the annual total liabilities of OPTIMI HEALTH CORP. from 2022 to 2025.

Year Total Liabilities Change
2025-09-30 €8.64 Million
≈ $10.10 Million
+73.70%
2024-09-30 €4.98 Million
≈ $5.82 Million
+51.65%
2023-09-30 €3.28 Million
≈ $3.84 Million
+311.30%
2022-09-30 €797.66K
≈ $932.55K
--

About OPTIMI HEALTH CORP.

F:8BN Germany Drug Manufacturers - Specialty & Generic
Market Cap
$23.08 Million
€19.74 Million EUR
Market Cap Rank
#25359 Global
#2190 in Germany
Share Price
€0.20
Change (1 day)
-3.77%
52-Week Range
€0.08 - €0.26
All Time High
€0.58
About

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of m… Read more